322 related articles for article (PubMed ID: 18339310)
1. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells.
Zhao YM; Li JY; Lan JP; Lai XY; Luo Y; Sun J; Yu J; Zhu YY; Zeng FF; Zhou Q; Huang H
Biochem Biophys Res Commun; 2008 May; 369(4):1114-9. PubMed ID: 18339310
[TBL] [Abstract][Full Text] [Related]
2. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization of long-term cultured human mesenchymal stem cells.
Kim J; Kang JW; Park JH; Choi Y; Choi KS; Park KD; Baek DH; Seong SK; Min HK; Kim HS
Arch Pharm Res; 2009 Jan; 32(1):117-26. PubMed ID: 19183884
[TBL] [Abstract][Full Text] [Related]
5. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
6. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
[TBL] [Abstract][Full Text] [Related]
7. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
8. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
9. Inducible immortality in hTERT-human mesenchymal stem cells.
Piper SL; Wang M; Yamamoto A; Malek F; Luu A; Kuo AC; Kim HT
J Orthop Res; 2012 Dec; 30(12):1879-85. PubMed ID: 22674533
[TBL] [Abstract][Full Text] [Related]
10. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.
Abdallah BM; Haack-Sørensen M; Burns JS; Elsnab B; Jakob F; Hokland P; Kassem M
Biochem Biophys Res Commun; 2005 Jan; 326(3):527-38. PubMed ID: 15596132
[TBL] [Abstract][Full Text] [Related]
12. Telomere stability and telomerase in mesenchymal stem cells.
Serakinci N; Graakjaer J; Kolvraa S
Biochimie; 2008 Jan; 90(1):33-40. PubMed ID: 18029083
[TBL] [Abstract][Full Text] [Related]
13. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro.
Moriscot C; de Fraipont F; Richard MJ; Marchand M; Savatier P; Bosco D; Favrot M; Benhamou PY
Stem Cells; 2005 Apr; 23(4):594-603. PubMed ID: 15790780
[TBL] [Abstract][Full Text] [Related]
14. Alternative lengthening of telomeres in mammalian cells.
Henson JD; Neumann AA; Yeager TR; Reddel RR
Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
[TBL] [Abstract][Full Text] [Related]
15. Immortalized cells with no detectable telomerase activity. A review.
Reddel RR; Bryan TM; Murnane JP
Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
[TBL] [Abstract][Full Text] [Related]
16. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.
Shahdadfar A; Frønsdal K; Haug T; Reinholt FP; Brinchmann JE
Stem Cells; 2005 Oct; 23(9):1357-66. PubMed ID: 16081661
[TBL] [Abstract][Full Text] [Related]
17. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
Xia Z; Locklin RM; Triffitt JT
Eur J Cell Biol; 2008 Jun; 87(6):353-64. PubMed ID: 18417247
[TBL] [Abstract][Full Text] [Related]
18. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.
Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR
Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140
[TBL] [Abstract][Full Text] [Related]
19. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow.
Sanz C; Vázquez P; Blázquez C; Barrio PA; Alvarez Mdel M; Blázquez E
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E634-43. PubMed ID: 20040695
[TBL] [Abstract][Full Text] [Related]
20. [Telomerase activity of human bone marrow mesenchymal stem cells].
Li JY; La XY; Luo Y; Sun J; Yu J; Lan JP; Zhu YY; Tan YM; Lin MF; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 33(6):481-5. PubMed ID: 15586402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
